© 2021 BioMarin. All rights reserved.

Pioneers in Rare Disease

Established in 1997, BioMarin is a world leader in developing and commercialising first- or best-in-class therapies for rare genetic diseases. We take pride in going where the science leads us, pioneering breakthrough treatments for debilitating and life-threatening conditions where we can significantly improve upon the current standard of care.

Our culture revolves around the ethos that no disease should go untreated, and our people are driven to discover, develop, and commercialise medicines that give patients, their families, and their caregivers hope where there was little or none. We fuel our R&D engine by looking for opportunities that align with our strengths and competencies. And we relentlessly pursue exciting, early-stage science that has the potential to change the course of disease.

Our employees feel connected to their work at BioMarin because they believe in our purpose: the patient. The passion and dedication that our employees bring to work each day is a testament to the inspiration our patients provide, and the knowledge of the impact we can make in their lives.

BioMarin at a Glance

  • Headquarters

    San Rafael, California

  • Founded


  • Chairman and CEO

    Jean-Jacques Bienaimé

  • Employees


  • Focus

    Rare genetic diseases

  • Therapy Areas

    Types of MPS
    CLN2 Disease

  • Research Areas

    Severe Haemophilia A
    Hereditary Angioedema

Boy with blue bike
Diseases & Conditions

We focus on rare conditions where we believe we can make a meaningful impact.

Learn More about Diseases & Conditions
Manufacturing Excellence

We take pride in manufacturing complex therapies for the patients who need them most.

Learn More about our manufacturing
Lab tech looking at test tube
Funding & Support

We support programmes and activities that foster excellence in patient care and provide valuable scientific, medical, and educational information.

Learn More Funding & Support